CDEK
← All organizations

Tourmaline Bio

For profitWebsite ↗

Also known as: Tourmaline Bio

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Dec 31, 2023

Last known activity

May 15, 2024

Acquired by Novartis on Sep 9, 2025

Timeline

2020s

  1. Jan 1, 2021

    Tourmaline Bio— Founded

  2. Sep 9, 2025

    Novartis— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

Recent trials (2)

Details

Founded
New York, NY, US Jan 1, 2021
Last known activity
May 15, 2024